Namisaki T, Kaji K, Shimozato N, Kaya D, et al. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis. Indian J Gastroenterol 2022 Mar 12. pii: 10.1007/s12664-021-01220.
PMID: 35279807